Bangkok, Thailand, July 9, 2026 – Cygnus Biosciences (Beijing) Co., Ltd., an innovator dedicated to developing proprietary sequencing technologies and platforms that power the future of sequencing, is showcasing its high-performance, user-centric sequencing solutions, the GS200 and GP1000 sequencing systems, at WHX Bangkok 2026.
Designed to support a wide range of next-generation sequencing (NGS) applications, the GS200 and GP1000 sequencers deliver the flexibility, accuracy, and scalability required across life science research, clinical diagnostics, pharmaceutical development, agricultural genomics, customs and biosecurity, public health surveillance, and forensic science. Together, they empower research insitutes, laboratories and industry partners to accelerate genomic discovery and advance precision medicine worldwide.
End-to-End Sequencing Solutions for Every Laboratory
Cygnus Biosciences provides comprehensive sequencing platforms that combine proprietary technology with user-centric design to meet the evolving needs of laboratories. From compact benchtop instruments to production-scale sequencing systems, the company's portfolio supports diverse NGS workflows with reliable performance, operational flexibility, and high-quality data output.
GS200 Benchtop Sequencer: Flexible Performance for Everyday NGS
GS200 is a desktop sequencer characterized by its small size, intuitive controls, flexible output, high precision and multi-scene applicability. Cygnus Biosciences, relying on the world's new core sequencing technologies, has realized sequencing reactions with long-length, fast speed and high precision, and its data quality is as high as Q40. The GS200 is compatible with mainstream library with a wide dynamic range of input, flexible run start, and no wait times. It can meet the needs of most scenarios.
GS200 Sequencer Highlights：
1、High Precision
• Q40 ≥ 85%
• Detection of low-frequency mutations
2、Fast Speed
• 6.5h
• Meet the needs of applications such as NIPT, mNGS, PGT-A and beyond
3、Flexible Deployment
• Flexible run start, avoids waiting
• Compatible with mainstream libraries
• Supports a wide range of sequencing reagent specifications, such as SE50, SE100, SE200, PE100 and PE150
GP1000 Production-Scale Sequencing System: High Throughput Meets Operational Efficiency
The GP1000 sequencing system is equipped with Cygnus Biosciences’ fully self-developed LumoSeq technology and AttoSeal technology, achieving excellent sequencing quality and compatibility with various libraries to meet sequencing needs across different fields. The GP1000 sequencing system features simple operation, dual flowcell platform with independent operation, and flexible throughput and read length modes, helping you unlock the secrets of life and explore endless possibili ties!
GP1000 Highlights
1、High Precision
Q40 Efficient data output ≥ 85%
2、High cost-effectiveness
• High Data Utilization Rate
• Does not require a balanced library
3、Flexible deployment
• Independent dual flowcell platform
• Comprehensive coverage of application
Strengthening Genomic Innovation Across Asia-Pacific
Asia-Pacific remains a key strategic market for Cygnus Biosciences, driven by the rapid adoption of genomic technologies and growing demand for next-generation sequencing across research, clinical, and public health sectors.
Cygnus is committed to strengthening partnerships throughout the region by working closely with local distributors, research institutions, healthcare providers, and industry partners. Together, we aim to expand NGS applications, accelerate scientific innovation, and support the continued advancement of precision healthcare across APAC.
